GlassScriptPhysician profile
William L Downey, JR.
NPI 1477533867
$1,915.90
in general payments reported to CMS, 2019-2025
18 companies · $524 in 2025
The $524 reported for 2025 was more than what 94% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $262 · 2020: $130 · 2021: $87.85 · 2022: $225 · 2023: $475 · 2024: $212 · 2025: $524.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,211.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,210.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $428.61 | 2019-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Glaxosmithkline, LLC. | $293.82 | 2019-2025 | Bexsero, Pediarix, Penmenvy |
| Sanofi Pasteur INC. | $232.98 | 2022-2025 | |
| Pfizer INC. | $171.66 | 2021-2024 | |
| Genzyme Corporation | $152.56 | 2025 | |
| Cranial Technologies, INC | $128.88 | 2022-2024 | Doc Band |
| Abbvie INC. | $116.27 | 2020 | |
| Intrabio INC | $115.96 | 2025 | Aqneursa |
| Neos Therapeutics, LP | $61.58 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $32.96 | 2025 | Zoryve |
| Astrazeneca Pharmaceuticals LP | $29.17 | 2024 | Flumist Quadrivalent |
| Tris Pharma INC | $27.16 | 2025 | Dyanavel Xr |
| Kaleo, INC. | $25.78 | 2022 | |
| Novo Nordisk INC | $23.74 | 2023 | |
| Corium, LLC | $23.15 | 2024 | Azstarys |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $21.86 | 2025 | Daybue |
| Sobi, INC | $15.89 | 2019 | |
| Supernus Pharmaceuticals, INC. | $13.87 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Downey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.